Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Bladder Cancer

Free Subscription Articles published in Oncogene Retrieve available abstracts of 25 articles: HTML format

Single Articles

January 2024
1. CAI H, Ke ZB, Chen JY, Li XD, et al
   Ubiquitin-specific protease 5 promotes bladder cancer progression through stabilizing Twist1.
   Oncogene. 2024 Jan 13. doi: 10.1038/s41388-023-02936.
   PubMed     Abstract available
   
   
   
2. ZHOU F, Deng Z, Shen D, Lu M, et al
   DLGAP5 triggers proliferation and metastasis of bladder cancer by stabilizing E2F1 via USP11.
   Oncogene. 2024 Jan 5. doi: 10.1038/s41388-023-02932.
   PubMed     Abstract available
   
   
   December 2023
3. YU J, Li M, Ju L, Zhou F, et al
   TRAIP suppresses bladder cancer progression by catalyzing K48-linked polyubiquitination of MYC.
   Oncogene. 2023 Dec 20. doi: 10.1038/s41388-023-02922.
   PubMed     Abstract available
   
   
   November 2023
4. RAMAL M, Corral S, Kalisz M, Lapi E, et al
   The urothelial gene regulatory network: understanding biology to improve bladder cancer management.
   Oncogene. 2023 Nov 23. doi: 10.1038/s41388-023-02876.
   PubMed     Abstract available
   
   
   August 2023
5. XIE J, Zhang H, Wang K, Ni J, et al
   M6A-mediated-upregulation of lncRNA BLACAT3 promotes bladder cancer angiogenesis and hematogenous metastasis through YBX3 nuclear shuttling and enhancing NCF2 transcription.
   Oncogene. 2023 Aug 23. doi: 10.1038/s41388-023-02814.
   PubMed     Abstract available
   
   
   May 2023
6. JIA Y, Ding X, Zhou L, Zhang L, et al
   Retraction Note: Mesenchymal stem cells-derived exosomal microRNA-139-5p restrains tumorigenesis in bladder cancer by targeting PRC1.
   Oncogene. 2023 May 30. doi: 10.1038/s41388-023-02726.
   PubMed    
   
   
   March 2023
7. NEYRET-KAHN H, Fontugne J, Meng XY, Groeneveld CS, et al
   Epigenomic mapping identifies an enhancer repertoire that regulates cell identity in bladder cancer through distinct transcription factor networks.
   Oncogene. 2023 Mar 22. doi: 10.1038/s41388-023-02662.
   PubMed     Abstract available
   
   
   
8. SUN J, Zhang H, Wei W, Xiao X, et al
   Regulation of CD8(+) T cells infiltration and immunotherapy by circMGA/HNRNPL complex in bladder cancer.
   Oncogene. 2023 Mar 3. doi: 10.1038/s41388-023-02637.
   PubMed     Abstract available
   
   
   September 2022
9. LIU W, Shen D, Ju L, Zhang R, et al
   MYBL2 promotes proliferation and metastasis of bladder cancer through transactivation of CDCA3.
   Oncogene. 2022 Sep 7. pii: 10.1038/s41388-022-02456.
   PubMed     Abstract available
   
   
   July 2022
10. LIU F, Zhang H, Xie F, Tao D, et al
    Correction: Hsa_circ_0001361 promotes bladder cancer invasion and metastasis through miR-491-5p/MMP9 axis.
    Oncogene. 2022 Jul 7. pii: 10.1038/s41388-022-02358.
    PubMed    
    
    
    June 2022
11. ZHENG X, Liu Z, Zhong J, Zhou L, et al
    Downregulation of HINFP induces senescence-associated secretory phenotype to promote metastasis in a non-cell-autonomous manner in bladder cancer.
    Oncogene. 2022 Jun 6. pii: 10.1038/s41388-022-02371.
    PubMed     Abstract available
    
    
    February 2022
12. BAKER SC, Mason AS, Slip RG, Skinner KT, et al
    Induction of APOBEC3-mediated genomic damage in urothelium implicates BK polyomavirus (BKPyV) as a hit-and-run driver for bladder cancer.
    Oncogene. 2022 Feb 22. pii: 10.1038/s41388-022-02235.
    PubMed     Abstract available
    
    
    November 2021
13. LIU XQ, Shao XR, Liu Y, Dong ZX, et al
    Tight junction protein 1 promotes vasculature remodeling via regulating USP2/TWIST1 in bladder cancer.
    Oncogene. 2021 Nov 15. pii: 10.1038/s41388-021-02112.
    PubMed     Abstract available
    
    
    October 2021
14. REN S, Zhang N, Shen L, Lu Y, et al
    Lnc00892 competes with c-Jun to block NCL transcription, reducing the stability of RhoA/RhoC mRNA and impairing bladder cancer invasion.
    Oncogene. 2021 Oct 6. pii: 10.1038/s41388-021-02033.
    PubMed     Abstract available
    
    
    
15. KOMURA K, Inamoto T, Tsujino T, Matsui Y, et al
    Increased BUB1B/BUBR1 expression contributes to aberrant DNA repair activity leading to resistance to DNA-damaging agents.
    Oncogene. 2021;40:6210-6222.
    PubMed     Abstract available
    
    
    September 2021
16. CHEN X, Chen H, Yao H, Zhao K, et al
    Turning up the heat on non-immunoreactive tumors: pyroptosis influences the tumor immune microenvironment in bladder cancer.
    Oncogene. 2021 Sep 29. pii: 10.1038/s41388-021-02024.
    PubMed     Abstract available
    
    
    
17. CHEN X, Xu R, He D, Zhang Y, et al
    CD8(+) T effector and immune checkpoint signatures predict prognosis and responsiveness to immunotherapy in bladder cancer.
    Oncogene. 2021 Sep 22. pii: 10.1038/s41388-021-02019.
    PubMed     Abstract available
    
    
    
18. TAN P, Wang M, Zhong A, Wang Y, et al
    SRT1720 inhibits the growth of bladder cancer in organoids and murine models through the SIRT1-HIF axis.
    Oncogene. 2021 Sep 1. pii: 10.1038/s41388-021-01999.
    PubMed     Abstract available
    
    
    March 2021
19. ZHENG R, Du M, Ge Y, Gao F, et al
    Identification of low-frequency variants of UGT1A3 associated with bladder cancer risk by next-generation sequencing.
    Oncogene. 2021 Mar 3. pii: 10.1038/s41388-021-01672.
    PubMed     Abstract available
    
    
    February 2021
20. YAN Q, Zeng P, Zhou X, Zhao X, et al
    RBMX suppresses tumorigenicity and progression of bladder cancer by interacting with the hnRNP A1 protein to regulate PKM alternative splicing.
    Oncogene. 2021 Feb 9. pii: 10.1038/s41388-021-01666.
    PubMed     Abstract available
    
    
    January 2021
21. XIONG Y, Ju L, Yuan L, Chen L, et al
    KNSTRN promotes tumorigenesis and gemcitabine resistance by activating AKT in bladder cancer.
    Oncogene. 2021 Jan 15. pii: 10.1038/s41388-020-01634.
    PubMed     Abstract available
    
    
    December 2020
22. ROSE M, Maurer A, Wirtz J, Bleilevens A, et al
    Correction: EGFR activity addiction facilitates anti-ERBB based combination treatment of squamous bladder cancer.
    Oncogene. 2020 Dec 1. pii: 10.1038/s41388-020-01534.
    PubMed     Abstract available
    
    
    October 2020
23. JIA Y, Ding X, Zhou L, Zhang L, et al
    Mesenchymal stem cells-derived exosomal microRNA-139-5p restrains tumorigenesis in bladder cancer by targeting PRC1.
    Oncogene. 2020 Oct 29. pii: 10.1038/s41388-020-01486.
    PubMed     Abstract available
    
    
    
24. JIN Y, Zhou Y, Deng W, Wang Y, et al
    Genome-wide profiling of BK polyomavirus integration in bladder cancer of kidney transplant recipients reveals mechanisms of the integration at the nucleotide level.
    Oncogene. 2020 Oct 13. pii: 10.1038/s41388-020-01502.
    PubMed     Abstract available
    
    
    September 2020
25. ROSE M, Maurer A, Wirtz J, Bleilevens A, et al
    EGFR activity addiction facilitates anti-ERBB based combination treatment of squamous bladder cancer.
    Oncogene. 2020 Sep 25. pii: 10.1038/s41388-020-01465.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.